AzurRx BioPharma, Inc. AZRX
3.45 +3.45
Day range unavailable
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 16.00 +363.8% upside
Now 3.45
- Target (low)
- 8.00
- Target (mean)
- 16.00
- Target (high)
- 20.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 4
- 2 months ago 4
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.80 | -0.88 – -0.70 | -4.70 | +83.0% | 0 | 0.0% | 3 |
| Next quarter | -0.83 | -1.05 – -0.60 | -3.10 | +73.2% | 0 | 0.0% | 3 |
| Current year | -4.37 | -6.80 – -3.10 | -11.50 | +62.0% | 0 | 0.0% | 3 |
| Next year | -3.72 | -5.29 – -2.50 | -4.37 | +14.9% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 2, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 1, 2021 | Roth Capital | Maintained | — | Buy |
| Apr 1, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 1, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Sep 26, 2019 | H.C. Wainwright | Reiterated | — | Buy |
| Apr 18, 2019 | H.C. Wainwright | Maintained | Buy | Buy |
| Feb 14, 2019 | Maxim Group | Initiated | — | Buy |
| Jan 25, 2019 | Roth Capital | Initiated | — | Buy |
| Jul 24, 2017 | H.C. Wainwright | Initiated | — | Buy |